FACTS 001: Characteristics of Participants Enrolled in a Phase III Randomised Controlled Trial of Tenofovir Gel for Prevention of HIV-1 and HSV-2
dc.contributor.author | Delany-Moretlwe, Sinead | en |
dc.contributor.author | Smith, Emilee | en |
dc.contributor.author | Myer, Landon | en |
dc.contributor.author | Ahmed, Khatija | en |
dc.contributor.author | Nkala, Busi | en |
dc.contributor.author | Maboa, Rebone | en |
dc.contributor.author | Gama, Cynthia | en |
dc.contributor.author | Sibiya, Sydney | en |
dc.contributor.author | Sebe, Modulakgotla | en |
dc.contributor.author | Brumskine, William | en |
dc.contributor.author | Bekker, Linda-Gail | en |
dc.contributor.author | Nchabeleng, Maposhane | en |
dc.contributor.author | Lombard, Carl | en |
dc.contributor.author | Gray, Glenda | en |
dc.contributor.author | Rees, Helen | en |
dc.date.accessioned | 2016-01-28T10:41:47Z | en |
dc.date.available | 2016-01-28T10:41:47Z | en |
dc.date.epub | 2014-10-30 | en |
dc.date.issued | 2014 | en |
dc.identifier.citation | Delany-Moretlwe Sinead, Smith Emilee, Myer Landon, Ahmed Khatija, Nkala Busi, Maboa Rebone, Gama Cynthia, Sibiya Sydney, Sebe Modulakgotla, Brumskine William, Bekker Linda-Gail, Nchabeleng Maposhane, Lombard Carl, Gray Glenda, Rees Helen, and FACTS 001 Study Group. AIDS Research and Human Retroviruses. October 2014, 30(S1): A281-A282. doi:10.1089/aid.2014.5637.abstract. | en |
dc.identifier.doi | 10.1089/aid.2014.5637.abstract. | en |
dc.identifier.eissn | 1931-8405 | en |
dc.identifier.issn | 0889-2229 | en |
dc.identifier.journal | AIDS Research and Human Retroviruses | en |
dc.identifier.uri | http://hdl.handle.net/11288/595092 | en |
dc.language.iso | en | en |
dc.relation.url | http://online.liebertpub.com/doi/abs/10.1089/aid.2014.5637.abstract | en |
dc.research.unit | Biostatistics Unit | en |
dc.research.unit | MRC Office of AIDS Research | en |
dc.subject | Tenofovir Gel | en |
dc.subject | Controlled Trial | en |
dc.subject | Prevention | en |
dc.subject | HIV-1 | en |
dc.subject | HSV-2 | en |
dc.subject | Randomised controlled trial | en |
dc.title | FACTS 001: Characteristics of Participants Enrolled in a Phase III Randomised Controlled Trial of Tenofovir Gel for Prevention of HIV-1 and HSV-2 | en |
dc.type | Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Delany-Moretlwe S_2014_FACTS001-Characteristics of.pdf
- Size:
- 81.68 KB
- Format:
- Adobe Portable Document Format
- Description:
- Main Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: